Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Voyageur Pharmaceuticals Ltd.

Market Cap 2.15Cr 1.52Cr 1.33Cr 1.22Cr 1.15Cr 143.38Cr 2.17Cr 15Cr 5.65Cr 71Cr 5.71Cr 5.59Cr 244.91Cr P/E 2024
-5.24x
P/E 2025 -7.5x
Enterprise Value 2.13Cr 1.51Cr 1.31Cr 1.21Cr 1.14Cr 141.84Cr 2.14Cr 14Cr 5.59Cr 70Cr 5.65Cr 5.53Cr 242.28Cr EV / Sales 2024
-
EV / Sales 2025 2,42,35,81,172x
Free-Float
93.03%
Yield 2024 *
-
Yield 2025 -
1 week+5.56%
Current month+11.76%
3 months-32.14%
6 months-42.42%
Current year-44.12%
1 week 0.09
Extreme 0.09
0.1
1 month 0.07
Extreme 0.07
0.1
Current year 0.07
Extreme 0.07
0.19
1 year 0.07
Extreme 0.07
0.36
3 years 0.04
Extreme 0.035
0.36
5 years 0.04
Extreme 0.035
0.36
10 years 0.04
Extreme 0.035
0.36
Manager TitleAgeSince
Chief Executive Officer - 01/07/2019
Director of Finance/CFO - 17/08/2022
Chief Tech/Sci/R&D Officer - 17/09/2024
Director TitleAgeSince
Director/Board Member - 06/12/2017
Director/Board Member - 01/07/2019
Chairman - 30/04/2025
Date Insider Type Main position Quantity % Market Cap.
05/06Sell

Director

2,00,000 0.1114%
05/06Sell

Chief Financial Officer

1,00,000 0.0557%
05/06Sell

Director

5,00,000 0.2786%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.56%-59.57%+46.15% 1.53Cr
-0.76%-5.06%+40.40%+143.87% 99TCr
-1.84%-3.85%+52.04%+39.62% 56TCr
-1.82%-3.50%+16.93%+57.38% 39TCr
-2.90%+0.68%+24.66%+16.53% 33TCr
-2.36%-3.12%+24.71%+12.95% 28TCr
-2.45%-2.88%+24.29%+29.93% 28TCr
-1.91%-0.87%-41.95%-48.26% 20TCr
-1.71%-5.25%+15.83%+46.76% 18TCr
-1.87%-2.30%+13.86%+58.24% 16TCr
Average -1.86%-0.13%+11.12%+40.32% 33.71TCr
Weighted average by Cap. -1.81%-0.49%+28.09%+63.21%

Financials

2024 2025
Net sales - 0.01 0.01 0.01 0.01 0.01 0.78 0.01 0.08 0.03 0.38 0.03 0.03 1.33
Net income -17.07L -12.08L -10.52L -10L -9L -11Cr -17.19L -1.15Cr -44.83L -5.61Cr -45.34L -44.37L -19Cr -35.33L -24.99L -21.78L -20.07L -18.88L -24Cr -35.57L -2.39Cr -92.75L -12Cr -93.81L -91.8L -40Cr
Net Debt -1L -79.69T -69.43T -64.01T -60.2T -75.1L -1L -8L -3L -37.01L -3L -3L -1.28Cr -2L -2L -1L -1L -1L -1.54Cr -2L -15.59L -6L -75.76L -6L -6L -2.63Cr
Logo Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine active pharmaceutical ingredients (API) and imaging contrast agents for medical radiology. It focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
Employees
-
Date Price Change Volume
19/26/19 0.0950 $ 0.00% 3,97,514
17/26/17 0.0950 $ 0.00% 72,829
15/26/15 0.0950 $ +5.56% 39,400
12/26/12 0.0900 $ 0.00% 27,000
11/26/11 0.0900 $ -10.00% 13,500

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!